In this study, treatment guided by NT-proBNP plasma levels did not improve the time-to-first HF hospitalisation nor the cardiovascular death rate (adjusted hazard ratio [HR], 0.98; 95% CI 0.79–1.22; p = 0.88). Here, NPPB is linked to hydrops fetalis.